Money & MarketsThe only reason more Americans haven’t quit their jobs is healthcareUpdated July 20, 2022
Money & MarketsWe are addressing vaccine hesitancy among pregnant women the wrong wayUpdated July 20, 2022
Tech & InnovationWhy giving away its covid patents to poor countries is a smart move for MerckUpdated July 20, 2022
Money & MarketsVaccine mandates may accomplish what the defund-the-police movement could notUpdated July 20, 2022
Money & MarketsA shocking number of US nurses are quitting, but a majority would stay for more moneyUpdated July 20, 2022
Tech & InnovationThe chances of having a C-section are shaped by a doctor’s previous patientUpdated July 20, 2022
Money & MarketsUS doctors keep lobbying for things that make American healthcare so expensiveUpdated July 20, 2022
Money & MarketsWith its e-cigarette authorization, the FDA is buying into Big Tobacco’s narrativeUpdated July 20, 2022
Money & MarketsInvestment in mental health treatments is beginning to catch up to the demandUpdated July 20, 2022
Money & MarketsLatinos have fewer objections, but more obstacles, to getting their kids vaccinatedUpdated July 20, 2022
Money & MarketsPrices for emergency medical flights are rising along with cases of Covid-19Updated July 20, 2022
Tech & InnovationMerck’s new Covid-19 drug could be one of the most lucrative drugs everUpdated July 20, 2022
Money & MarketsOfficial US data on police violence missed half the killings of the past 40 yearsUpdated July 20, 2022
Tech & InnovationIn a 29-country study of Covid’s impact on life expectancy, US men fared the worstUpdated July 20, 2022
Tech & InnovationWhy is Pfizer advertising a vaccine that gets plenty of free promotion?Updated July 20, 2022
Money & MarketsCovid has spurred a digital cash revolution in developing countriesUpdated July 20, 2022
Money & MarketsItaly added vaccine passports, and domestic tourism is as high as everUpdated July 20, 2022
Money & MarketsUS hospitals are losing more nurses than ever to lucrative contract workUpdated July 20, 2022
